Torrent Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	19,113	16,564	12,452	7,772	12,519
Depreciation & Amortization	7,740	7,748	6,830	6,427	6,399
Other Amortization	209.3	204.6	190.3	192.8	174
Loss (Gain) From Sale of Assets	-13.4	-883.6	-216.2	8.2	13
Asset Writedown & Restructuring Costs	-	129.7	45.6	2.3	4.8
Loss (Gain) From Sale of Investments	-167.3	-179.9	-195.1	-101.4	-155.8
Provision & Write-off of Bad Debts	17.7	70.8	22.7	9	144.2
Other Operating Activities	3,762	4,826	4,734	7,239	4,338
Change in Accounts Receivable	171.7	783.2	-2,897	-1,091	652.1
Change in Inventory	-2,622	-494.3	2,557	2,189	-5,330
Change in Accounts Payable	-2,777	4,136	-580.2	-3,924	1,295
Change in Other Net Operating Assets	418.1	-243.6	738.3	-692.5	-
Operating Cash Flow	25,851	32,661	23,681	18,030	20,054
Operating Cash Flow Growth	-20.85%	37.92%	31.34%	-10.09%	43.97%
Capital Expenditures	-6,119	-4,328	-5,739	-2,026	-3,352
Sale of Property, Plant & Equipment	177.7	1,337	1,587	67.9	11.3
Cash Acquisitions	-	-	-20,000	-	-
Investment in Securities	337.9	1,181	-129.8	-80.9	-1,207
Other Investing Activities	202.6	131.2	129	72.4	52.5
Investing Cash Flow	-5,401	-1,679	-24,153	-1,966	-4,494
Short-Term Debt Issued	-	-	8,420	2,186	-
Long-Term Debt Issued	-	-	13,950	-	8,950
Total Debt Issued	-	-	22,370	2,186	8,950
Short-Term Debt Repaid	-3,963	-1,334	-	-	-3,789
Long-Term Debt Repaid	-5,564	-12,599	-9,936	-10,651	-14,724
Total Debt Repaid	-9,527	-13,933	-9,936	-10,651	-18,513
Net Debt Issued (Repaid)	-9,527	-13,933	12,434	-8,464	-9,563
Common Dividends Paid	-10,830	-10,153	-5,132	-6,769	-3,385
Other Financing Activities	-2,622	-3,710	-3,030	-2,577	-3,561
Financing Cash Flow	-22,980	-27,796	773.6	-17,811	-16,508
Foreign Exchange Rate Adjustments	-87.3	80.7	211.2	5.3	56
Miscellaneous Cash Flow Adjustments	-	-	588.3	-	-
Net Cash Flow	-2,617	3,266	1,101	-1,742	-892.6
Free Cash Flow	19,732	28,333	17,942	16,004	16,702
Free Cash Flow Growth	-30.35%	57.92%	12.11%	-4.18%	69.37%
Free Cash Flow Margin	17.14%	26.41%	18.65%	18.81%	20.87%
Free Cash Flow Per Share	58.30	83.72	53.01	47.29	49.35
Cash Interest Paid	2,622	3,710	3,030	2,577	3,561
Cash Income Tax Paid	6,028	4,981	3,981	4,210	1,755
Levered Free Cash Flow	12,787	22,213	14,783	10,209	7,970
Unlevered Free Cash Flow	14,358	24,417	16,860	11,790	10,163
Change in Working Capital	-4,809	4,181	-182	-3,519	-3,383

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.